Pawel Kapelski

Pawel Kapelski

Auto-generated profile, based on publicly available information

Pawel Kapelski

Department of Psychiatric Genetics, Poznań University of Medical Sciences, Poznań, Poland

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in Schizophrenia Research
Verified
Journal Article
Closed access
PKPawel Kapelski
Pawel Kapelski
MSMaria Skibińska
Maria Skibińska
MMMalgorzata Maciukiewicz
Malgorzata Maciukiewicz
Monika Wiłkość-DębczyńskaMonika Wiłkość-Dębczyńska
Monika Wiłkość-Dębczyńska
DFDorota Frydecka
Dorota Frydecka
JTJoanna Twarowska-Hauser
Joanna Twarowska-Hauser

8 September 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MSMaria Skibińska
Maria Skibińska
PKPawel Kapelski
Pawel Kapelski
MDMonika Dmitrzak-Węglarz
Monika Dmitrzak-Węglarz
NLNatalia Lepczynska
Natalia Lepczynska
JPJoanna Pawlak
Joanna Pawlak
ARAleksandra Rajewska-Rager
Aleksandra Rajewska-Rager
Bipolar disorder (BD) is a chronic mental disorder that affects more than 1% of the population worldwide. Over 65% of patients experience early onset of the disease. Most cases of juvenile bipolar disorder begin with a depressed mood episode, and up to 50% of youth initially diagnosed with major depression go onto developing a BD. Our study aimed to find biomarkers of diagnosis conversion in young patients with mood disorders. We performed a two-year follow-up study on 79 adolescent patients diagnosed with MDD or BD, with a detailed clinical assessment at five visits. We monitored diagnosis change from MDD to BD. The control group consisted of 31 healthy youths. According to the neurodevelopmental and neuroimmunological hypotheses of mood disorders, we analyzed serum levels of brain-derived neurotrophic factor (BDNF), proBDNF, epidermal growth factor (EGF), migration inhibitory factor (MIF), stem cell factor (SCF), and correlations with clinical factors. We detected a significant disease-dependent increase in EGF level in MDD and BP patients at baseline exacerbation of depressive or hypomanic/manic episodes as well as in euthymic state compared to healthy controls. No potential biological predictors of disease conversion were found. Replication studies on a larger cohort of patients are needed.

27 April 2021 in The World Journal of Biological Psychiatry
Verified
Journal Article
Closed access
MDMonika Dmitrzak-Węglarz
Monika Dmitrzak-Węglarz
Aleksandra SzczepankiewiczAleksandra Szczepankiewicz
Aleksandra Szczepankiewicz
JRJanusz Kazimierz Rybakowski
Janusz Kazimierz Rybakowski
PKPaweł Kapelski
Paweł Kapelski
KBKarolina Bilska
Karolina Bilska
JPJoanna Pawlak
Joanna Pawlak
A significant challenge in psychiatry is the differential diagnosis of depressive episodes in the course of mood disorders. Gene expression profiling may provide an opportunity for such distinguish...

22 February 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ARAleksandra Rajewska-Rager
Aleksandra Rajewska-Rager
MDMonika Dmitrzak-Węglarz
Monika Dmitrzak-Węglarz
NLNatalia Lepczynska
Natalia Lepczynska
PKPawel Kapelski
Pawel Kapelski
JPJoanna Pawlak
Joanna Pawlak
MSMaria Skibińska
Maria Skibińska
The heterogeneity of symptoms in young patients with major depression disorder makes it difficult to properly identify and diagnose. Therefore, the appropriate evaluation of mood symptoms is important in early intervention. The aim of this study was to (a) establish dimensions of the Hamilton Depression Rating Scale (HDRS-17) in adolescents and young adults and (b) perform correlations between the identified dimensions and psychological variables (impulsivity, personality traits). This study enrolled 52 young patients with major depression disorder (MDD). The severity of the depressive symptoms was established using the HDRS-17. The factor structure of the scale was studied using the principal component analysis (PCA) with varimax rotation. The patients completed the self-reported Barratt Impulsiveness Scale (BIS-11) and Temperament and Character Inventory (TCI). The three dimensions of the HDRS-17 identified as core in adolescent and young patients with MDD were (1) psychic depression/motor retardation, (2) disturbed thinking, and (3) sleep disturbances/anxiety. In our study, dimension 1 correlated with reward dependence and cooperativeness; dimension 2 correlated with non-planning impulsivity, harm avoidance, and self-directedness; and dimension 3 correlated with reward dependence. Conclusions: Our study supports the previous findings, which indicate that a certain set of clinical features (including the HDRS-17 dimensions, not only total score) may represent a vulnerability pattern that characterizes patients with depression.

1 December 2016 in Archivum Immunologiae et Therapiae Experimentalis
Verified
Journal Article
Closed access
PDF file
PKPawel Kapelski
Pawel Kapelski
MSMaria Skibińska
Maria Skibińska
MMMalgorzata Maciukiewicz
Malgorzata Maciukiewicz
JPJoanna Pawlak
Joanna Pawlak
MDMonika Dmitrzak-Weglarz
Monika Dmitrzak-Weglarz
JTJoanna Twarowska-Hauser
Joanna Twarowska-Hauser
IL1 gene complex has been implicated in the etiology of schizophrenia. To assess whether IL1 gene complex is associated with susceptibility to schizophrenia in Polish population we conducted family-based study. Functional polymorphisms from IL1A (rs1800587, rs17561, rs11677416), IL1B (rs1143634, rs1143643, rs16944, rs4848306, rs1143623, rs1143633, rs1143627) and IL1RN (rs419598, rs315952, rs9005, rs4251961) genes were genotyped in 143 trio with schizophrenia. Statistical analysis was performed using transmission disequilibrium test. We have found a trend toward an association of rs1143627, rs16944, rs1143623 in IL1B gene with the risk of schizophrenia. Our results show a protective effect of allele T of rs4251961 in IL1RN against schizophrenia. We also performed haplotype analysis of IL1 gene complex and found a trend toward an association with schizophrenia of GAGG haplotype (rs1143627, rs16944, rs1143623, rs4848306) in IL1B gene, haplotypes: TG (rs315952, rs9005) and TT (rs4251961, rs419598) in IL1RN. Haplotype CT (rs4251961, rs419598) in IL1RN was found to be associated with schizophrenia. After correction for multiple testing associations did not reach significance level. Our results might support theory that polymorphisms of interleukin 1 complex genes (rs1143627, rs16944, rs1143623, rs4848306 in IL1B gene and rs4251961, rs419598, rs315952, rs9005 in IL1RN gene) are involved in the pathogenesis of schizophrenia, however, none of the results reach significance level after correction for multiple testing.

1 August 2016 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
PKPawel Kapelski
Pawel Kapelski
MSMaria Skibińska
Maria Skibińska
MMMalgorzata Maciukiewicz
Malgorzata Maciukiewicz
JPJoanna Pawlak
Joanna Pawlak
DZDorota Zaremba
Dorota Zaremba
JTJoanna Twarowska-Hauser
Joanna Twarowska-Hauser